Trial intelligence / Profile preview

Paclitaxel/Cisplatin vs 5-Fluorouracil/Cisplatin with RT for Muscle-Invading Bladder Cancer

NCT00055601Phase 2Completed

Sponsor
NRG Oncology
Start
Dec 2002
Primary completion
Oct 2010
Modality
Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of Paclitaxel Micelles for Injection, fluorouracil in bladder cancer, sponsored by NRG Oncology. Started Dec 2002; status: completed.

02

Drugs

Paclitaxel Micelles for Injectionfluorouracil
03

Conditions

bladder cancer

Beyond the preview

Go deeper on NCT00055601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00055601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call